STEVEN NAVARRO: Open Payments
NPI 1013598960 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $201 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $31 |
| Lundbeck LLC | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: UBRELVY, REXULTI, MOUNJARO, Ozempic, AUSTEDO XR, CAPVAXIVE, Diagnostic ECG Service, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
